Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
364-06-004 ISMRM Abstract

Differentiating Cervical Cancer Subtypes Using Diffusion MRI: More b Values or More Diffusion Times?

Primary: Body - Uterus
Secondary: Diffusion - Diffusion Modeling
364-06-004 · Classification in Diffusion MRI II · Monday, 11 May, 5:05 PM–6:00 PM · Digital Posters Row E
Keywords: Diffusion MRI MR cytometry IVIM DKI Cervical cancer Multiple diffusion times
Accepted
Zhilin Yuan 1, Diwei Shi2,3, Chen Wang1, Fan Liu4, Jing Chen1, Xinyu Liu1, Yilan Ji5, Baiyan Su1, Jinxia ZHU6, Thorsten Feiweier7, Zhengyu Jing1, Junzhong Xu8,9, Hua Guo4, Yuan Li10, Yonglan He1, Huadan Xue1
1Peking Union Medical College Hospital, Beijing, China
2Research Institute of Tsinghua University in Shenzhen, China
3Tsinghua Shenzhen International Graduate School, Tsinghua University, Beijing, China
4Tsinghua University, Beijing, China
5Beijing National Day School, Beijing, China
6MR Research Collaboration, Siemens Healthineers Ltd., Beijing, China
7Siemens Healthineers AG, Erlangen, Germany
8Department of Biomedical Engineering, Vanderbilt University, Nashville, United States of America
9Institute of Imaging Science;, Vanderbilt University Medical Center, Nashville, United States of America
10Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Presenting Author: Zhilin Yuan

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. [1]Baek, M.H., Park, J.Y., Kim, D., Suh, D.S., Kim, J.H., Kim, Y.M., Kim, Y.T., and Nam, J.H. (2014). Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery. Gynecol Oncol 135, 462-467. 10.1016/j.ygyno.2014.10.004. [doi]
2. [2]El-Zein, M., and Franco, E.L. (2025). Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination. Expert Rev Mol Diagn 25, 157-164. 10.1080/14737159.2025.2486653. [doi]
3. [3]Fujii, S., Gonda, T., and Yunaga, H. (2024). Clinical Utility of Diffusion-Weighted Imaging in Gynecological Imaging: Revisited. Invest Radiol 59, 78-91. 10.1097/rli.0000000000001004. [doi]
4. [4]Haldorsen, I.S., Lura, N., Blaakær, J., Fischerova, D., and Werner, H.M.J. (2019). What Is the Role of Imaging at Primary Diagnostic Work-Up in Uterine Cervical Cancer? Curr Oncol Rep 21, 77. 10.1007/s11912-019-0824-0. [doi]
5. [5]Iima, M., Yamamoto, A., Kataoka, M., Yamada, Y., Omori, K., Feiweier, T., and Togashi, K. (2019). Time-dependent diffusion MRI to distinguish malignant from benign head and neck tumors. J Magn Reson Imaging 50, 88-95. 10.1002/jmri.26578. [doi]
6. [6]Jiang, X., Devan, S.P., Xie, J., Gore, J.C., and Xu, J. (2022). Improving MR cell size imaging by inclusion of transcytolemmal water exchange. NMR Biomed 35, e4799. 10.1002/nbm.4799. [doi]
7. [7]Jiang, X., Li, H., Devan, S.P., Gore, J.C., and Xu, J. (2021). MR cell size imaging with temporal diffusion spectroscopy. Magn Reson Imaging 77, 109-123. 10.1016/j.mri.2020.12.010. [doi]
8. [8]Moukarzel, L.A., Angarita, A.M., VandenBussche, C., Rositch, A., Thompson, C.B., Fader, A.N., and Levinson, K. (2017). Preinvasive and Invasive Cervical Adenocarcinoma: Preceding Low-Risk or Negative Pap Result Increases Time to Diagnosis. J Low Genit Tract Dis 21, 91-96. 10.1097/lgt.0000000000000286. [doi]
9. [9]Wu, D., Jiang, K., Li, H., Zhang, Z., Ba, R., Zhang, Y., Hsu, Y.C., Sun, Y., and Zhang, Y.D. (2022). Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer. Radiology 303, 578-587. 10.1148/radiol.211180. [doi]
10. [10]Xiao, M.L., Fu, L., Ma, F.H., Li, Y.A., Zhang, G.F., and Qiang, J.W. (2024). Comparison of MRI features among squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, usual-type endocervical adenocarcinoma and gastric adenocarcinoma of cervix. Magn Reson Imaging 112, 10-17. 10.1016/j.mri.2024.06.002. [doi]
11. [11]Xu, J., Devan, S.P., Shi, D., Pamulaparthi, A., Yan, N., Zu, Z., Smith, D.S., Harkins, K.D., Gore, J.C., and Jiang, X. (2025). MATI: A GPU-accelerated toolbox for microstructural diffusion MRI simulation and data fitting with a graphical user interface. Magn Reson Imaging 122, 110428. 10.1016/j.mri.2025.110428. [doi]
12. [12]Yokoi, E., Mabuchi, S., Takahashi, R., Matsumoto, Y., Kuroda, H., Kozasa, K., and Kimura, T. (2017). Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma. J Gynecol Oncol 28, e19. 10.3802/jgo.2017.28.e19. [doi]
13. [13]Zhang, Y., Shu, P., Wang, X., Ouyang, G., Zhou, J., Zhao, Y., Li, Z., Wang, Y., and Shen, Y. (2024). Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis. J Cancer 15, 6326-6335. 10.7150/jca.100653. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/364-06-004